
The AbbVie Patient Assistance Foundation concentrates almost all of its funding on direct patient pharmaceutical assistance, providing prescription medicines at no charge to eligible individuals. Its recorded grants are two very large, program-specific disbursements to lists of eligible individuals, indicating an operational focus on patient access to medications rather than general philanthropic causes. There is no evidence of place-based or diverse sector giving—funding is tightly focused on medication assistance and related patient supports.
Very large, aggregated program disbursements to lists of eligible individuals (few grants representing many individual beneficiaries)
Notable grantees: 83839 ELIGIBLE INDIVIDUALS LIST AVA, 51261 ELIGIBLE INDIVIDUALS LIST AVA
Abbvie Patient Assistance Foundation’s recorded grantmaking is almost entirely centered on one activity: providing pharmaceutical care at no charge to eligible individuals. The two largest recent grants, totaling more than $964 million across 2023 and 2024, went to eligible-individual lists for that purpose, showing a funding model built around direct medication access rather than broad discretionary philanthropy. That focus makes the foundation unusual among grantmakers because its largest recorded awards are not to nonprofit programs or institutions, but to patient lists tied to prescription support. In 2024, it gave $610,336,691 to the 83839 Eligible Individuals List Ava in Wisconsin; in 2023, it gave $353,952,408 to the 51261 Eligible Individuals List Ava, also in Wisconsin. Those awards point to a highly operational structure in which grant dollars are used to subsidize medicine directly. The foundation’s public programs also include patient assistance and educational or research grant channels, but the grant record provided here is dominated by direct patient pharmaceutical support.
The clearest theme in the record is medication access. In 2024, Abbvie Patient Assistance Foundation granted $610,336,691 to the 83839 Eligible Individuals List Ava for providing pharmaceutical care at no charge to eligible individuals. A year earlier, it gave $353,952,408 to the 51261 Eligible Individuals List Ava for the same purpose. Beyond that core patient-assistance pattern, the foundation’s active programs point to other health-related funding lanes. It offers Independent Educational Grants for third-party educational activities in medical, health, and professional education. It also lists an Investigator-Initiated Studies program for external clinical studies, indicating some support for research led by outside investigators. The AbbVie Foundation Grants program extends into community development, education, health system strengthening, and disaster relief.
The distribution of recent grant sizes is extremely large: p25 is $418,048,479, the median is $482,144,550, and p75 is $546,240,620. The record shows only two recent grants, both in back-to-back years, which suggests repeated support rather than a one-off payment. Abbvie Patient Assistance Foundation is classified as a regular funder, not a DAF, and it does not fund individuals in the usual philanthropic sense; the grants listed are tied to patient-access lists. The grant record provided does not show an application process for these patient-assistance disbursements. Its active programs do include some unsolicited channels, such as Independent Educational Grants, Investigator-Initiated Studies, and myAbbVie Assist.
$964.3M
$49.9M
$619.1M
$610.4M
Most grants fall between $418M and $546.2M, with a median of $482.1M.
25th Percentile
$418M
Median
$482.1M
75th Percentile
$546.2M
About 0% of grants go to recipients in WI.
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
The grant record is narrowly local and U.S.-based. Both recent grants went to recipients in Wisconsin, which is also the top state by grant count. The recipient-country distribution is entirely domestic, with 2 grants in the United States and none outside the country. The grants shown were awarded to eligible-individual lists in Wisconsin rather than to a broad set of cities or regions, so the geographic pattern is defined more by patient location than by institutional reach. The foundation’s headquarters is in North Chicago, Illinois, but none of the recent grants were recorded in Illinois.
Its recorded grantmaking is centered on providing pharmaceutical care at no charge to eligible individuals. The two recent grants listed were both made for that purpose, and both were directed to eligible-individual lists in Wisconsin.
The recent grant-size distribution is very large: p25 is $418,048,479, the median is $482,144,550, and p75 is $546,240,620. The two grants on file were $353,952,408 in 2023 and $610,336,691 in 2024.
Wisconsin is the top state by grant count. The two recent grants in the record were both tied to Wisconsin-based eligible-individual lists, while none of the recent grants were recorded in Illinois.
Yes. Active programs listed include AbbVie Foundation Grants, Independent Educational Grants, Investigator-Initiated Studies, and myAbbVie Assist. The first supports community development, education, health systems, and disaster relief; the others support educational activities, external clinical studies, and patient access to AbbVie medicines.
The grant record provided is dominated by patient pharmaceutical assistance, but the active program list also includes educational grants, investigator-initiated studies, and a broader AbbVie Foundation Grants program that supports nonprofit and community partners.
2024
Source: IRS Form 990-PF, fiscal year 2024.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| 83839 ELIGIBLE INDIVIDUALS LIST AVA | NA, WI | $610,336,691 | 2024 | PROVIDE PHARMACEUTICAL CARE AT NO CHARGE TO ELIGIBLE INDIVIDUALS |
| 51261 ELIGIBLE INDIVIDUALS LIST AVA | NA, WI | $353,952,408 | 2023 | PROVIDE PHARMACEUTICAL CARE AT NO CHARGE TO ELIGIBLE INDIVIDUALS |
83839 ELIGIBLE INDIVIDUALS LIST AVA
$610,336,691PROVIDE PHARMACEUTICAL CARE AT NO CHARGE TO ELIGIBLE INDIVIDUALS
51261 ELIGIBLE INDIVIDUALS LIST AVA
$353,952,408PROVIDE PHARMACEUTICAL CARE AT NO CHARGE TO ELIGIBLE INDIVIDUALS